Aceragen Stock Current Valuation
| ACGNDelisted Stock | 0.75 0.23 23.47% |
Valuation analysis of Aceragen helps investors to measure Aceragen's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Overvalued
Today
Please note that Aceragen's price fluctuation is very steady at this time. Calculation of the real value of Aceragen is based on 3 months time horizon. Increasing Aceragen's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Aceragen is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Aceragen Stock. However, Aceragen's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.75 | Real 0.71 | Hype 0.75 | Naive 0.75 |
The intrinsic value of Aceragen's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Aceragen's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Aceragen helps investors to forecast how Aceragen stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Aceragen more accurately as focusing exclusively on Aceragen's fundamentals will not take into account other important factors: Aceragen Company Current Valuation Analysis
Aceragen's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
CompetitionIn accordance with the recently published financial statements, Aceragen has a Current Valuation of 0.0. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The current valuation for all United States stocks is 100.0% higher than that of the company.
Aceragen Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Aceragen's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Aceragen could also be used in its relative valuation, which is a method of valuing Aceragen by comparing valuation metrics of similar companies.Aceragen is currently under evaluation in current valuation category among its peers.
Aceragen Fundamentals
| Revenue | 4.86 M | |||
| EBITDA | (11.58 M) | |||
| Net Income | (23.36 M) | |||
| Total Debt | 560 K | |||
| Cash Flow From Operations | (24.5 M) | |||
| Number Of Employees | 26 | |||
| Total Asset | 101.11 M | |||
| Retained Earnings | (758.82 M) | |||
| Working Capital | (3.56 M) | |||
| Z Score | -10.88 | |||
| Net Asset | 101.11 M |
About Aceragen Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Aceragen's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Aceragen using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Aceragen based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Aceragen
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Aceragen position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aceragen will appreciate offsetting losses from the drop in the long position's value.Moving against Aceragen Stock
| 0.54 | CSCO | Cisco Systems Sell-off Trend | PairCorr |
| 0.54 | CAT | Caterpillar Fiscal Year End 3rd of February 2025 | PairCorr |
| 0.53 | AXP | American Express Fiscal Year End 24th of January 2025 | PairCorr |
| 0.53 | CVX | Chevron Corp Sell-off Trend | PairCorr |
| 0.51 | DIS | Walt Disney Sell-off Trend | PairCorr |
The ability to find closely correlated positions to Aceragen could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Aceragen when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Aceragen - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Aceragen to buy it.
The correlation of Aceragen is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Aceragen moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Aceragen moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Aceragen can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Other Consideration for investing in Aceragen Stock
If you are still planning to invest in Aceragen check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Aceragen's history and understand the potential risks before investing.
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |